Teva Pharmaceuticals (TEVA) has a pullback pattern on declining volume and Clive Corcoran thinks it could be a relatively attractive reward/risk proposition on the long side.
The indices had a down day to begin the week, but once again a snapback in the last hour and a half brought them substantially off the lows and pared back the losses.
Copyright 2026 Tiger Shark Publishing LLC . All rights reserved.
It should not be assumed that the methods, techniques, or indicators presented on these websites will be profitable or that they will not result in losses. Past results are not necessarily indicative of future results. Examples presented on these websites are for educational purposes only. These set-ups are not solicitations of any order to buy or sell. The authors, Tiger Shark Publishing LLC, and all affiliates assume no responsibility for your trading results. There is a high degree of risk in trading.